Literature DB >> 12091813

Homograft conduit failure in infants is not due to somatic outgrowth.

Winfield J Wells1, Hector Arroyo, Ross M Bremner, John Wood, Vaughn A Starnes.   

Abstract

OBJECTIVE: It has been assumed that the need for homograft replacement is due to somatic outgrowth, but this has not been adequately studied. Our objective was to identify reasons for homograft conduit failure.
METHODS: The records and imaging studies of 40 patients undergoing homograft conduit replacement of the right ventricular outflow tract from 1996 to 2000 were retrospectively reviewed.
RESULTS: The majority of patients had a diagnosis of tetralogy of Fallot (n = 20) and truncus arteriosus (n = 13). The median age at the initial operation was 8 months (0.25-108 months). The initial homograft sizes ranged from 9 to 22 mm, and 28 conduits were of pulmonary origin. When comparing size of the initial homograft with patients' expected pulmonary valve diameter (z = 0), oversizing was noted to be +3 (range, 0.83-5.4). Median interval to conduit failure was 5.3 years (0.83-11.3 years). At homograft replacement, only 12 patients had an existing conduit that was 1 SD below the homograft conduit size needed (z < or = -1). Most conduits had important regurgitation, but this was rarely a primary reason for reintervention (n = 1). Reoperation was usually required for stenosis, with a median gradient of 53 mm Hg (20-140 mm Hg). Stenosis was further categorized angiographically as follows: homograft valvular stenosis (shrinkage; 21/40 [53%]), distal anastomotic stenosis (4/40 [10%]), conduit kinking (3/40 [8%]), sternal compression (3/40 [8%]), posterior shelf impingement (2/40 [5%]), and somatic outgrowth (3/40 [8%]). Replacement in 2 patients was for proximal hood aneurysm. Several patients (7/40 [18%]) had stenosis at multiple levels. The average decrease in conduit diameter was 47% (28%-73%).
CONCLUSIONS: Somatic outgrowth is seldom a primary reason for homograft conduit replacement of the right ventricular outflow tract. The most common cause for failure is conduit obstruction with thickening and shrinkage at the annular area. Conduit stenosis was responsible for failure in 53% of patients, technical issues were responsible for 30%, and only 8% failed as a result of somatic outgrowth. Placement of a smaller homograft (z = 0) at the initial operation may decrease the incidence of conduit kinking, sternal compression, and posterior shelf impingement.

Entities:  

Mesh:

Year:  2002        PMID: 12091813     DOI: 10.1067/mtc.2002.121158

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

Review 1.  In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.

Authors:  Benjamin Smood; Hidetaka Hara; David C Cleveland; David K C Cooper
Journal:  Ann Thorac Surg       Date:  2019-03-02       Impact factor: 4.330

2.  Right ventricle to pulmonary artery conduit augmentation compared with replacement in young children.

Authors:  Justin P V Zachariah; Frank A Pigula; John E Mayer; Doff B McElhinney
Journal:  Ann Thorac Surg       Date:  2009-08       Impact factor: 4.330

3.  Quantitative assessment of homograft function 1 year after insertion into the pulmonary position: impact of in situ homograft geometry on valve competence.

Authors:  Johannes Nordmeyer; Victor Tsang; Régis Gaudin; Philipp Lurz; Alessandra Frigiola; Alexander Jones; Silvia Schievano; Carin van Doorn; Philipp Bonhoeffer; Andrew M Taylor
Journal:  Eur Heart J       Date:  2009-06-04       Impact factor: 29.983

4.  Replacement of valved right ventricular to pulmonary artery conduits: an observational study with focus on right ventricular geometry.

Authors:  Tsvetomir Loukanov; Christian Sebening; Wolfgang Springer; Markus Khalil; Herbert E Ulmer; Siegfried Hagl; Matthias Karck; Matthias Gorenflo
Journal:  Clin Res Cardiol       Date:  2007-11-28       Impact factor: 5.460

5.  The Contegra conduit: Late outcomes in right ventricular outflow tract reconstruction.

Authors:  Anthony A Holmes; Steve Co; Derek G Human; Jacques G Leblanc; Andrew Im Campbell
Journal:  Ann Pediatr Cardiol       Date:  2012-01

6.  Percutaneous pulmonary valve implantation in patients with right ventricular outflow tract dysfunction: a systematic review and meta-analysis.

Authors:  Liyu Ran; Wuwan Wang; Francesco Secchi; Yajie Xiang; Wenhai Shi; Wei Huang
Journal:  Ther Adv Chronic Dis       Date:  2019-06-14       Impact factor: 5.091

Review 7.  Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction.

Authors:  Chenggang Li; Bo Xie; Ruizhe Tan; Lijin Liang; Zhaoxiang Peng; Qi Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-04

8.  Hand-Made Polytetrafluoroethylene Tricuspid-Valved Conduit for Surgical Reconstruction of the Right Ventricular Outflow Tract in a Child With Truncus Arteriosus.

Authors:  Vishal V Bhende; Tanishq S Sharma; Hardil P Majmudar; Krishnan Ganapathy Subramaniam; Deepakkumar V Mehta; Amit Kumar; Purvi R Patel; Gurpreet Panesar; Kunal Soni; Kartik B Dhami; Nirja Patel; Sohilkhan R Pathan
Journal:  Cureus       Date:  2022-07-20

9.  Pulmonary valve replacement after right ventricular outflow tract reconstruction with homograft vs Contegra®: a case control comparison of mortality and morbidity.

Authors:  Nicolas Poinot; Jean-Francois Fils; Hélène Demanet; Hugues Dessy; Dominique Biarent; Pierre Wauthy
Journal:  J Cardiothorac Surg       Date:  2018-01-17       Impact factor: 1.637

Review 10.  Tissue Engineered Transcatheter Pulmonary Valved Stent Implantation: Current State and Future Prospect.

Authors:  Xiling Zhang; Thomas Puehler; Jette Seiler; Stanislav N Gorb; Janarthanan Sathananthan; Stephanie Sellers; Assad Haneya; Jan-Hinnerk Hansen; Anselm Uebing; Oliver J Müller; Derk Frank; Georg Lutter
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.